COVID-19 mortality in women and men in sub-Saharan Africa: a cross-sectional study.


Journal

BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275

Informations de publication

Date de publication:
11 2021
Historique:
received: 18 08 2021
accepted: 24 10 2021
entrez: 24 11 2021
pubmed: 25 11 2021
medline: 15 12 2021
Statut: ppublish

Résumé

Since sex-based biological and gender factors influence COVID-19 mortality, we wanted to investigate the difference in mortality rates between women and men in sub-Saharan Africa (SSA). We included 69 580 cases of COVID-19, stratified by sex (men: n=43 071; women: n=26 509) and age (0-39 years: n=41 682; 40-59 years: n=20 757; 60+ years: n=7141), from 20 member nations of the WHO African region until 1 September 2020. We computed the SSA-specific and country-specific case fatality rates (CFRs) and sex-specific CFR differences across various age groups, using a Bayesian approach. A total of 1656 deaths (2.4% of total cases reported) were reported, with men accounting for 70.5% of total deaths. In SSA, women had a lower CFR than men (mean [Formula: see text] = -0.9%; 95% credible intervals (CIs) -1.1% to -0.6%). The mean CFR estimates increased with age, with the sex-specific CFR differences being significant among those aged 40 years or more (40-59 age group: mean [Formula: see text] = -0.7%; 95% CI -1.1% to -0.2%; 60+ years age group: mean [Formula: see text] = -3.9%; 95% CI -5.3% to -2.4%). At the country level, 7 of the 20 SSA countries reported significantly lower CFRs among women than men overall. Moreover, corresponding to the age-specific datasets, significantly lower CFRs in women than men were observed in the 60+ years age group in seven countries and 40-59 years age group in one country. Sex and age are important predictors of COVID-19 mortality globally. Countries should prioritise the collection and use of sex-disaggregated data so as to design public health interventions and ensure that policies promote a gender-sensitive public health response.

Identifiants

pubmed: 34815243
pii: bmjgh-2021-007225
doi: 10.1136/bmjgh-2021-007225
pmc: PMC8611236
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Clin Infect Dis. 2020 Jul 28;71(15):863-865
pubmed: 32232322
Lancet Glob Health. 2021 Jan;9(1):e14-e15
pubmed: 33160453
BMJ Glob Health. 2020 Oct;5(10):
pubmed: 33028702
BMC Public Health. 2016 Nov 3;16(1):1136
pubmed: 27809824
J Glob Health. 2020 Dec;10(2):020513
pubmed: 33312506
Clin Infect Dis. 2020 Dec 3;71(9):2488-2494
pubmed: 32473009
BMJ Glob Health. 2022 Apr;7(4):
pubmed: 35418411
Proc R Soc Lond A Math Phys Sci. 1946;186(1007):453-61
pubmed: 20998741
Am J Transl Res. 2020 Oct 15;12(10):6537-6548
pubmed: 33194050
Lancet. 2020 Mar 14;395(10227):846-848
pubmed: 32151325
AIDS Behav. 2020 Nov;24(11):2995-2998
pubmed: 32451937
Wien Klin Wochenschr. 2021 Apr;133(7-8):393-398
pubmed: 33351155
Front Med (Lausanne). 2020 Jun 23;7:348
pubmed: 32671082
PLoS One. 2021 Jun 14;16(6):e0253193
pubmed: 34125851
Lancet. 2020 Aug 22;396(10250):565-582
pubmed: 32828189
PLoS Negl Trop Dis. 2015 Jul 16;9(7):e0003846
pubmed: 26181387
SN Compr Clin Med. 2020;2(8):1069-1076
pubmed: 32838147
MD Comput. 1991 May-Jun;8(3):157-71
pubmed: 1857193
Lancet. 2012 Aug 11;380(9841):611-9
pubmed: 22883510
Nat Rev Immunol. 2016 Oct;16(10):626-38
pubmed: 27546235
Lancet Neurol. 2007 Mar;6(3):269-78
pubmed: 17303533
Nat Commun. 2020 Dec 9;11(1):6317
pubmed: 33298944
Lancet. 2020 Aug 22;396(10250):532-533
pubmed: 32798449
mBio. 2021 Feb 9;12(1):
pubmed: 33563817
Glob Health Action. 2014 May 05;7:23742
pubmed: 24804863
EClinicalMedicine. 2021 Sep;39:101054
pubmed: 34368662
Nat Med. 2020 Aug;26(8):1205-1211
pubmed: 32546824
Biol Sex Differ. 2020 May 25;11(1):29
pubmed: 32450906
J Med Virol. 2021 Mar;93(3):1449-1458
pubmed: 32790106
Arch Bronconeumol. 2021 Jan;57:21-34
pubmed: 34629638
BMJ Open. 2020 Oct 6;10(10):e040129
pubmed: 33028563
BMC Public Health. 2020 Nov 19;20(1):1742
pubmed: 33213391
Front Immunol. 2020 Aug 28;11:2147
pubmed: 32983176
BMJ. 2021 Feb 17;372:n334
pubmed: 33597166
Lancet. 2020 Sep 5;396(10252):649
pubmed: 32891195
Front Sociol. 2021 Jun 15;6:650729
pubmed: 34212026
Front Public Health. 2020 Apr 29;8:152
pubmed: 32411652
Lancet. 2019 Jun 22;393(10190):2535-2549
pubmed: 31155270
Front Immunol. 2021 Jun 17;12:693269
pubmed: 34220854
Lancet Glob Health. 2019 Oct;7(10):e1295-e1296
pubmed: 31537347

Auteurs

Jyoti Dalal (J)

Association Actions en Santé, The GRAPH Network, Geneve, Switzerland.

Isotta Triulzi (I)

Association Actions en Santé, The GRAPH Network, Geneve, Switzerland.
Institute of Management, Scuola Superiore Sant'Anna, Pisa, Italy.

Ananthu James (A)

Association Actions en Santé, The GRAPH Network, Geneve, Switzerland.
Department of Chemical Engineering, Indian Institute of Science, Bangalore, India.

Benedict Nguimbis (B)

Association Actions en Santé, The GRAPH Network, Geneve, Switzerland.

Gabriela Guizzo Dri (GG)

Association Actions en Santé, The GRAPH Network, Geneve, Switzerland.
Institute of Global Health, University of Geneva, Geneva, Switzerland.

Akarsh Venkatasubramanian (A)

Association Actions en Santé, The GRAPH Network, Geneve, Switzerland.
Gender, Equality, Diversity and Inclusion Deparment, International Labour Organization, Geneve, Switzerland.

Lucie Noubi Tchoupopnou Royd (L)

Association Actions en Santé, The GRAPH Network, Geneve, Switzerland.
Health Systems Strengthening and Development Group Center, Yaounde, Cameroon.

Sara Botero Mesa (S)

Association Actions en Santé, The GRAPH Network, Geneve, Switzerland.
Institute of Global Health, University of Geneva, Geneva, Switzerland.

Claire Somerville (C)

The Gender Center, Institute of International and Development Studies, Geneva, Switzerland.

Giuseppe Turchetti (G)

Institute of Management, Scuola Superiore Sant'Anna, Pisa, Italy.

Beat Stoll (B)

Association Actions en Santé, The GRAPH Network, Geneve, Switzerland.
Institute of Global Health, University of Geneva, Geneva, Switzerland.

Jessica Lee Abbate (JL)

Association Actions en Santé, The GRAPH Network, Geneve, Switzerland.
UMI TransVIHMI, Montpellier, Languedoc-Roussillon, France.
Geomatys, Montpellier, France.

Franck Mboussou (F)

World Health Organization Regional Office for Africa, Brazzaville, Brazzaville, Congo.

Benido Impouma (B)

Association Actions en Santé, The GRAPH Network, Geneve, Switzerland.
World Health Organization Regional Office for Africa, Brazzaville, Brazzaville, Congo.

Olivia Keiser (O)

Association Actions en Santé, The GRAPH Network, Geneve, Switzerland Olivia.Keiser@unige.ch.
Institute of Global Health, University of Geneva, Geneva, Switzerland.

Flávio Codeço Coelho (FC)

Association Actions en Santé, The GRAPH Network, Geneve, Switzerland.
School of Applied Mathematics, Getulio Vargas Foundation, Rio de Janeiro, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH